Conatus Pharmaceuticals (CNAT) Misses Q1 EPS by 1c

May 5, 2016 8:31 AM EDT
Get Alerts CNAT Hot Sheet
Price: $0.56 --0%

Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE

Conatus Pharmaceuticals (NASDAQ: CNAT) reported Q1 EPS of ($0.36), $0.01 worse than the analyst estimate of ($0.35).

Cash, cash equivalents and marketable securities were $32.6 million at March 31, 2016, compared with $36.5 million at December 31, 2015. The company believes current financial resources are sufficient to maintain operations and ongoing clinical development activities for at least the next 12 months.

For earnings history and earnings-related data on Conatus Pharmaceuticals (CNAT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings